The filing is a routine advance notice of a small insider sale. Monitor for the actual Form 4 filing to confirm execution, but the amount is too small to warrant a trading response. No material read-through for the stock.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 3 $155.47entry
- T+1 · 2mo ago +1.14%α +1.52% · $157.24
- T+5 · 2mo ago −3.43%α −2.29% · $150.13
- T+20 · 7w ago −14.79%α −13.61% · $132.47
- T+51 · todayOpen
- T+60 · in 13d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director Christopher Kiritsy filed a Form 144 notice of intent to sell 375 shares of Palvella Therapeutics, valued at approximately $58,875, from a stock option exercise. The proposed sale is immaterial relative to the company's $2.2B market cap and represents a routine insider transaction with no meaningful signal.
Key Facts
- Insider: Director Christopher P. Kiritsy
- Proposed sale: 375 shares, estimated value $58,875
- Shares acquired via stock option exercise on the same date
- Sale planned for 09/02/2026 on NASDAQ
- Amount represents ~0.0027% of $2.2B market cap
Financial Impact
Proceeds of ~$58,875 from a director's sale; negligible relative to market cap.
Risk Factors
- None material, the proposed sale is trivial in size and from a director, not top management.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-008991 |
| Document: 0001950047-26-008991-index.html | 0001950047-26-008991 |
| Document: 0001950047-26-008991.txt | 0001950047-26-008991 |
Track record
36 reports on PVLA
4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +35.07% at T+60 after the May 15, 2026 report. 8 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $145.21 Now $144.60 −0.42% settles Dec 16
- Nov 10, 20266d ago 144 Neutral 5/10 Entry $163.94 Now $144.60 −11.80% settles Dec 10
- Nov 5, 202611d ago 8-K Bullish 7/10 Entry $156.85 Now $144.60 −7.81% settles Dec 4
- Nov 5, 202611d ago Press Release Neutral 6/10 No price data
- Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $152.93 Now $144.60 −5.45% settles Dec 2
- Oct 28, 202619d ago SC 13G/A Neutral 3/10 Entry $147.47 Now $144.60 −1.95% settles Nov 25
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $147.47 Now $144.60 −1.95% settles Nov 25
- Oct 28, 202619d ago Press Release Bullish 7/10 Entry $147.47 Now $144.60 −1.95% settles Nov 25
- Oct 23, 202624d ago Insider Cluster Neutral 2/10 Entry $126.23 Now $144.60 +14.55% settles Nov 23
- Oct 15, 20264w ago Press Release Neutral 4/10 Entry $127.34 to $153.18 Now $144.60 +13.55% ▲ +20.29% +22.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers